<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biomarkers | Drögemöller Lab</title>
    <link>/tag/biomarkers/</link>
      <atom:link href="/tag/biomarkers/index.xml" rel="self" type="application/rss+xml" />
    <description>Biomarkers</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 01 Feb 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>Biomarkers</title>
      <link>/tag/biomarkers/</link>
    </image>
    
    <item>
      <title>CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines</title>
      <link>/publication/drogemoller-cyp-2-d-6-2019/</link>
      <pubDate>Fri, 01 Feb 2019 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-cyp-2-d-6-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients</title>
      <link>/publication/zazuli-outcome-2019/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/zazuli-outcome-2019/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
